Click on the links below to view the latest news stories from leading media outlets highlighting ODPRN research and scientists.
“We assume that these people are friends and family of people who are at risk of an opioid overdose and want to have a naloxone kit on hand in case they are able to intervene to help save that person’s life,” said Dr. Tara Gomes
Patients with overactive bladder who were dispensed mirabegron did not have an increased risk for cardiovascular events compared with other treatments, according to a study published in JAMA Internal Medicine.
Meanwhile, a new report from the Ontario Drug Policy Research Network looked at 1,337 opioid-related deaths in the province from July 2017 to June 2018.
Of the 147,303 publicly funded naloxone kits distributed across the province between July 2017 and June 2018, 8,657 were handed out in the Middlesex-London Health Unit coverage area — a rate of 1,813 per 100,000 people — a new study by the ODPRN says.
Federal Health Minister Ginette Petitpas Taylor was at St. Michael’s Hospital on Wednesday morning to announce $10.7 million in funding to support a number of new initiatives focused on addressing Canada’s opioid crisis.
Study shows opioid guidelines unintentionally cause experiences of stigma and loss of autonomy amongst those who take opioids
Published in the International Journal of Drug Policy, a study conducted by the ODPRN of St. Michael’s Hospital found that the introduction of opioid-related policies had unintended consequences for people who take opioids.